News

Leader in organ transplant technologies secures institutional growth capital to drive organ preservation innovation and commercial expansion CAMBRIDGE, MASSACHUSETTS – March 7, 2023 – Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare Partners. This

GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak® Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation.1 CAMBRIDGE, MASSACHUSETTS – March 6, 2023 – Paragonix Technologies, Inc., a leading organ transplant

Watch the news at FOX 13 – WATCH: Mid-South man recalls receiving heart transplant from Baptist Memorial Hospital This is an episode of heart failure happens in the United States. Many patients end up needing heart transplants to stay alive. But keep it in mind, it is critical that the

From PSQH – FEBRUARY 10, 2023 The American Society for Artificial Internal Organs recently published new data in its ASAIO Journal from a study comparing hospital costs and clinical outcomes among heart transplant patients. Specifically, the study compared patients who received heart transplants preserved with Paragonix’s SherpaPak versus the common practice of consumer coolers with

UZ Leuven Lung Transplant Team utilized controlled hypothermic preservation provided by LUNGguard to preserve lungs between 4 and 8ºC, enabling next day recipient surgery CAMBRIDGE, MASSACHUSETTS – February 8, 2023 – Paragonix Technologies, Inc., a leading organ preservation provider, announced today a pioneering lung transplantation case in which donor lungs

From Medical Design Briefs – FEBRUARY 1, 2023 The latest developments in medical technologies — including the use of artificial intelligence, telehealth, integrated technologies, and data intelligence — are geared toward improving patient engagement. Clinical precision medicine, which includes leveraging the individual patient’s data, connecting the patient with their provider,